Filter zurücksetzen
Stichworte
Arzneimitteltherapie ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

187 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Cycle Dose Drug Form D2R Fallopian Tube Cancer (NCT00108745)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 41 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
Cycle Dose Drug Form, GOG-0212, Form D2R Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer NCT00108745 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E74972BD-ECF1-48B2-E034-0003BA3F9857

Cycle Dose Drug Form Fallopian Tube Cancer (NCT00262847)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 38 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
GOG-0218 Cycle Dose Drug Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer NCT00262847 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F11B7C47-A6FE-54E9-E034-0003BA3F9857

Cycle Dose Drug Form D2R Fallopian Tube Cancer (NCT00565851)

- 09.01.15 - 1 Formular, 2 Itemgruppen, 35 Datenelemente, 1 Sprache
Itemgruppen: Header, TREATMENT CYCLE AND MODIFICATION
GYNECOLOGIC ONCOLOGY GROUP Cycle Dose Drug Form - FORM D2R Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer NCT00565851 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA671E4E-F217-4DDB-E034-0003BA12F5E7

Cycle Dose Drug Form D2R Fallopian Tube Cancer (NCT00951496)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 41 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
Gynecologic Oncology Group Cycle Dose Drug Form (Form D2R) Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00951496 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F53E994-CCD2-730F-E044-0003BA3F9857

Cycle Dose Drug Form (D2R) Ovarian Cancer (NCT00954174)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 38 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
GOG-0261: Cycle Dose Drug Form (D2R) Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer NCT00954174 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=64F29740-0457-692F-E040-BB89AD432164

Sarcoma NCT01016730 Treatment - AMC-063 Velcade Administration Form (DA2) - 3021247v1.0 - Velcade Administration Form Sarcoma (AMC-063, DA2)

- 03.01.15 - 1 Formular, 5 Itemgruppen, 26 Datenelemente, 1 Sprache
Itemgruppen: Header module, Dose Escalation, Day 1, Day 8, Day 15
AMC-063 Velcade Administration Form (DA2) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma NCT01016730 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=817724CA-1778-200C-E040-BB89AD434BB8

Breast Cancer NCT00024102 Transmittal - CALGB 49907 CAPECITABINE DRUG SUPPLY RECORD FORM 2044684_v3_0 - CALGB: 49907 CAPECITABINE DRUG SUPPLY RECORD FORM

- 16.12.14 - 1 Formular, 2 Itemgruppen, 22 Datenelemente, 2 Sprachen
Itemgruppen: General information, Medication
CALGB: 49907 CAPECITABINE DRUG SUPPLY RECORD FORM Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50CE624-6F5F-37E3-E034-080020C9C0E0

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video